Delek US Holdings, Inc. filings document the formal reporting record for a downstream energy company with refining, logistics, pipeline, and renewable-fuels assets. Form 8-K disclosures cover operating and financial results, quarterly dividends, material agreements, credit-facility amendments, capital-structure changes, and executive leadership matters.
Proxy and annual-meeting filings describe board elections, executive compensation votes, the 2026 Long-Term Incentive Plan, auditor ratification, and shareholder voting results. The filings also identify Delek US common stock on the New York Stock Exchange and record its relationship with Delek Logistics Partners, LP, including general partner and majority limited partner interests.
Delek US Holdings, Inc. announced a leadership transition in its refining operations. Effective April 20, 2026, the company appointed Amber Russell as Executive Vice President, Refining, where she will lead refining operations and focus on operational excellence, safety, and strategic growth.
On the same date, Joseph Israel departed from his role as Executive Vice President, Refining and Renewables, and as an executive officer of Delek Logistics Partners, LP. Under a separation agreement, he will receive benefits outlined in his previously disclosed executive employment agreement, and the company will pay COBRA medical coverage costs for eighteen months. A related press release was furnished under Regulation FD.
Delek US Holdings, Inc. declared a quarterly cash dividend of $0.255 per share. The dividend will be paid on May 8, 2026 to shareholders of record as of May 1, 2026, providing ongoing cash returns to common stockholders.
Delek is a diversified downstream energy company with refining assets in Texas, Arkansas, and Louisiana, with a combined nameplate crude throughput capacity of 302,000 barrels per day. It also owns about 63.3% of Delek Logistics Partners, LP, a midstream master limited partnership.
Delek US Holdings amended its asset-based lending credit facility, increasing revolving loan commitments from $1,100.0 million to $1,250.0 million. The amendment also extends the Revolving Facility maturity from October 26, 2027 to April 9, 2031, reduces interest margins by 0.25%, and adjusts various covenant thresholds.
The amendment revises the incremental facility so Delek can expand available revolving borrowings by up to the greatest of $750.0 million, 100% of EBITDA, or adjusted plus suppressed availability, subject to conditions. The facility continues to be secured by first‑priority liens on substantially all tangible and intangible assets, with customary covenants and a minimum Fixed Charge Coverage Ratio of 1.00 to 1.00 when excess availability falls below set levels.
Delek US Holdings, Inc. director William J. Finnerty reported an open-market sale of 5,000 shares of Common Stock at $47.50 per share. The transaction was made pursuant to a Rule 10b5-1 trading plan. After this sale, he directly holds 36,369 shares.
Joseph Finnerty filed a Form 144 reporting dispositions of Common stock. The filing lists sales in March 2026: a $227,500 sale of 5,000 shares on 03/18/2026 and a $230,508 sale of 5,392 shares on 03/04/2026. The record also lists 5,000 Restricted Stock Units dated 06/10/2017 as the securities to be sold.
Delek US Holdings Inc: The Vanguard Group filed Amendment No. 10 to Schedule 13G/A reporting Amount beneficially owned: 0 and Percent of class: 0% in the issuer's Common Stock.
The filing states Vanguard completed an internal realignment on January 12, 2026 and, in accordance with SEC Release No. 34-39538, certain subsidiaries will report beneficial ownership separately going forward.
Delek US Holdings director Zohar Shlomo sold 7,343 shares of common stock in an open-market transaction at $46.00 per share. The sale occurred on March 19, 2026 and was executed under a pre-arranged Rule 10b5-1 trading plan. After this transaction, Shlomo directly holds 6,646 Delek US shares.
Director Ezra Uzi Yemin reported open-market sales totaling 55,356 shares of Delek US Holdings, Inc. common stock on March 18, 2026. The trades were executed at weighted average prices of $43.73 and $44.20 per share, across price ranges from $43.07 to $44.48.
After these sales, Yemin holds 228,419 shares directly and 569,651 shares indirectly through Yemin Investments, LP. The transactions were made under a pre-arranged Rule 10b5-1 trading plan, which indicates the timing was scheduled in advance rather than opportunistic.
Delek US Holdings director William J. Finnerty sold 5,000 shares of Common Stock in an open-market transaction at $45.50 per share. After the sale, he directly holds 41,369 shares. The transaction was executed under a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
DK filed a Form 144 reporting proposed sales of Common Stock through Fidelity Brokerage Services LLC on 03/19/2026. The filing lists recent open-market dispositions by Shlomo Zohar: 03/04/2026 7,343 shares for $315,749.00, 03/05/2026 22,029 shares for $987,633.50, and 03/09/2026 5,000 shares for $207,325.00.
The form also lists previously vested restricted stock awards with vesting dates and share counts (examples include 873 shares vested 06/10/2020 and 1,562 shares vested 12/10/2020), provided as background on the securities involved.